FDA-Inspected Site

Blair M. Brengle, M.D.

2 FDA inspections are on record for Blair M. Brengle, M.D. in Indianapolis, United States.

483· Form 483 issued

Indianapolis, United States · Last updated July 11, 2026

Overview

  • 2 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2024-08-29.

At a glance

Inspections

2

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
26 Aug 2024 – 29 Aug 2024Human Drugs483View 483 →
1 Jun 2021 – 8 Jul 2021Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

29 Aug 2024
21 CFR 312.62(b)

Case history records- inadequate or inadequate

Cited by Corrine M Carter, Victoria R Flournoy

29 Aug 2024
21 CFR 312.64(b)

Safety Reports - Non-Serious Events

Cited by Corrine M Carter, Victoria R Flournoy

8 Jul 2021
21 CFR 312.60

FD-1572, protocol compliance

Cited by Myra K Casey, Dina A Tallman

8 Jul 2021
21 CFR 312.60

Informed consent

Cited by Myra K Casey, Dina A Tallman

8 Jul 2021
21 CFR 312.62(b)

Case history records- inadequate or inadequate

Cited by Myra K Casey, Dina A Tallman

Investigators

FDA investigators tied to this site in the record.

Victoria R Flournoy1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 312.60Cited across public-safe Form 483 observations2x
21 CFR 312.62(b)Cited across public-safe Form 483 observations2x
21 CFR 312.64(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Blair M. Brengle, M.D.'s 2 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat